Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-02T22:48:13.696Z Has data issue: false hasContentIssue false

Chapter 3 - Mechanisms of bile formation and cholestasis

from Section I - Pathophysiology of pediatric liver disease

Published online by Cambridge University Press:  05 March 2014

Nikita A. Gupta
Affiliation:
Emory University School of Medicine, and Pediatric Hepatologist, Children’s Healthcare of Atlanta, GA, USA
Saul J. Karpen
Affiliation:
Emory University School of Medicine, Department of Pediatric Gastroenterology, Hepatology and Nutrition, Atlanta, GA, USA
Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Ronald J. Sokol
Affiliation:
University of Colorado Medical Center
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Get access

Summary

Cholestastic disorders comprise a large group of conditions affecting infants and children. Damage to the liver occurs from multiple effects of the various retained biliary constituents, including various lipids, toxins, and bile acids. Therefore impairments in bile flow and secretion – cholestasis – particularly in the infant liver, drive the development and progression of liver disease. With the recent findings of genetic causes of cholestasis (see Chapter 13), many of the previously labeled “indeterminate” or “idiopathic” forms of cholestasis have now been properly assigned to specific impairments in critical genes involved in the formation of bile, including a primary focus on genes for the canalicular transporters [1,2]. In a similar vein, exploration of the effects of various endogenous and exogenous factors on the expression and function of these same essential genes has led to a greater molecular understanding of acquired forms of cholestasis. It is now becoming increasingly possible to assign genetic contributors to both genetic and acquired forms of liver disease. In addition, we have an increased understanding of how these gene products are engaged in the response and adaptation to cholestasis, and, intriguingly, why these processes may not be fully adequate to protect the liver. In particular, see Stapelbroek et al. [1], Mullenbach and Lammert [2], and Karpen and Trauner [3], who discuss our increasing knowledge of the expression, structure, and regulation of these genes and gene products in the underlying processes that lead to cholestasis. It is now accepted that the processes of bile formation, cholestasis, and adaptation are inherently intertwined with structural, developmental, biochemical, intercellular communication, subcellular organization, cell signaling pathways, and physiological components of the liver and liver function. In this chapter, attention will focus upon the basic mechanisms of bile formation, as well as the genetic and acquired pathways that lead to cholestasis.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Stapelbroek, JM, van Erpecum, KJ, Klomp, LW, et al. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010;52:258–271.CrossRefGoogle ScholarPubMed
Mullenbach, R, Lammert, F. An update on genetic analysis of cholestatic liver diseases: digging deeper. Digest Dis 2011;29:72–77.CrossRefGoogle ScholarPubMed
Karpen, SJ, Trauner, M. The new therapeutic frontier: nuclear receptors and the liver. J Hepatol 2010;52:455–462.CrossRefGoogle ScholarPubMed
Nicolaou, M, Andress, E, Zolnerciks, J, et al. Canalicular ABC transporters and liver disease. J Pathol 2011:.
Kosters, A, Karpen, SJ. Bile acid transporters in health and disease. Xenobiotica 2008;38:1043–1071.CrossRefGoogle ScholarPubMed
Nathanson, MH, Boyer, JL. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551–566.CrossRefGoogle ScholarPubMed
Hofmann, AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol 2007;6:15–27.Google ScholarPubMed
Feranchak, AP, Sokol, RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001;21:471–488.CrossRefGoogle ScholarPubMed
Dawson, PA, Lan, T, Rao, A. Bile acid transporters. J Lipid Res 2009;50:2340–2357.CrossRefGoogle ScholarPubMed
Stieger, B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. In Page, CP, Rosenthal, W, Michel, MC, et al. (eds.) Handbook of Experimental Pharmacology. Heidelberg: Springer, 2011, pp. 205–259.Google Scholar
Suchy, FJ, Ananthanarayanan, M. Bile salt excretory pump: biology and pathobiology. J Pediatr Gastroenterol Nutr 2006;43(Suppl 1):S10–S16.CrossRefGoogle ScholarPubMed
Stieger, B. Recent insights into the function and regulation of the bile salt export pump (ABCB11). Curr Opin Lipidol 2009;20:176–181.CrossRefGoogle Scholar
Davit-Spraul, A, Gonzales, E, Baussan, C, et al. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010;30:134–146.CrossRefGoogle ScholarPubMed
Colombo, C, Vajro, P, Degiorgio, D, et al. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr 2011;52:73–83.CrossRefGoogle ScholarPubMed
Miettinen, TA, Klett, EL, Gylling, H, et al. Liver transplantation in a patient with sitosterolemia and cirrhosis. Gastroenterology 2006;130:542.CrossRefGoogle Scholar
Keitel, V, Nies, AT, Brom, M, et al. A common Dubin–Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003;284:G165–174.CrossRefGoogle Scholar
Mullenbach, R, Lammert, FC. The transporter “variome”: the missing link between gene variants and bile salt transporter function. Hepatology 2009;49:352–354.CrossRefGoogle ScholarPubMed
Byrne, JA, Strautnieks, SS, Ihrke, G, et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 2009;49:553–567.CrossRefGoogle ScholarPubMed
Hofmann, AF. The enterohepatic circulation of bile acids in man. Clin Gastroenterol 1977;6:3–24.Google ScholarPubMed
Jaeschke, H, Gores, GJ, Cederbaum, AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166–176.CrossRefGoogle ScholarPubMed
Wagner, M, Zollner, G, Trauner, M. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin Liver Dis 2010;30:160–177.CrossRefGoogle ScholarPubMed
Watkins, JB, Szczepanik, P, Gould, JB, et al. Bile salt metabolism in the human premature infant. Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital. Gastroenterology 1975;69:706–713.Google ScholarPubMed
Suchy, FJ, Balistreri, WF, Heubi, JE, et al. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology 1981;80:1037–1041.Google ScholarPubMed
Trauner, M, Halilbasic, E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011;140:1120–1125.CrossRefGoogle ScholarPubMed
Zollner, G, Trauner, M. Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol 2009;156:7–27.CrossRefGoogle ScholarPubMed
Khan, AA, Chow, EC, van Loenen-Weemaes, AM, et al. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur J Pharm Sci 2009;37:115–125.CrossRefGoogle ScholarPubMed
Lee, JM, Lee, YK, Mamrosh, JL, et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature 2011;474:506–510.CrossRefGoogle ScholarPubMed
Pols, TW, Noriega, LG, Nomura, M, et al. The bile acid membrane receptor TGR5: a valuable metabolic target. Digest Dis 2011;29:37–44.CrossRefGoogle ScholarPubMed
Osler, WH. Principles and Practice of Medicine, 4th edn. New York: Appleton, 1901.Google Scholar
Dunham, EC. Septicemia in the newborn. Am J Dis Children 1933;45:229–253.Google Scholar
Zimmerman, HJ, Fang, M, Utili, R, et al. Jaundice due to bacterial infection. Gastroenterology 1979;77:362–374.Google Scholar
Kosters, A, Karpen, SJ. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 2010;30:186–194.CrossRefGoogle ScholarPubMed
Bolder, U, Tonnu, HT, Schteingart, CD, et al. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997;112:214–225.CrossRefGoogle ScholarPubMed
Moshage, H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–266.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Trauner, M, Wagner, M, Fickert, P, et al. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 2005;39:S111–S124.CrossRefGoogle ScholarPubMed
Bolder, U, Jeschke, MG, Landmann, L, et al. Heat stress enhances recovery of hepatocyte bile acid and organic anion transporters in endotoxemic rats by multiple mechanisms. Cell Stress Chaperones 2006;11:89–100.CrossRefGoogle ScholarPubMed
Saeki, J, Sekine, S, Horie, T. LPS-induced dissociation of multidrug resistance-associated protein 2 (Mrp2) and radixin is associated with Mrp2 selective internalization in rats. Biochem Pharmacol 2011;81:178–184.CrossRefGoogle ScholarPubMed
Padda, MS, Sanchez, M, Akhtar, AJ, et al. Drug-induced cholestasis. Hepatology 2011;53:1377–1387.CrossRefGoogle ScholarPubMed
Tujios, S, Fontana, RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol 2011;8:202–211.CrossRefGoogle ScholarPubMed
Stieger, B, Geier, A. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opin Drug Metab Toxicol 2011;7:411–425.CrossRefGoogle ScholarPubMed
Kearns, GL, Abdel-Rahman, SM, Alander, SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157–1167.CrossRefGoogle ScholarPubMed
Russmann, S, Jetter, A, Kullak-Ublick, GA. Pharmacogenetics of drug-induced liver injury. Hepatology 2010;52:748–761.CrossRefGoogle ScholarPubMed
Zollner, G, Wagner, M, Trauner, M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Ther 2010;126:228–243.CrossRefGoogle ScholarPubMed
Abernathy, CO, Utili, R, Zimmerman, HJ. Immaturity of the biliary excretory system predisposes neonates to intrahepatic cholestasis. Med Hypoth 1979;5:641–647.CrossRefGoogle ScholarPubMed
Carter, BA, Shulman, RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastrol 2007;4:277–287.CrossRefGoogle ScholarPubMed
Carter, BA, Karpen, SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis 2007;27:251–258.CrossRefGoogle ScholarPubMed
Teitelbaum, DH, Han-Markey, T, Drongowski, RA, et al. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. J Parenter Enteral Nutr 1997;21:100–103.CrossRefGoogle ScholarPubMed
Colomb, V, Jobert-Giraud, A, Lacaille, F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000;24:345–350.CrossRefGoogle ScholarPubMed
El Kasmi, KC, Anderson, AL, Devereaux, MW, et al. Toll like receptor 4 dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition. Hepatology 2012;55:1518–1528.CrossRefGoogle Scholar
Kurvinen, A, Nissinen, MJ, Andersson, S, et al. Parenteral plant sterols and intestinal failure associated liver disease in neonates: a prospective nationwide study. J Pediatr Gastroenterol Nutr 2012;54:803–811.CrossRefGoogle Scholar
Wagner, M, Zollner, G, Trauner, M. Nuclear receptors in liver disease. Hepatology 2011;53:1023–1034.CrossRefGoogle ScholarPubMed
Boyer, JL. Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?Gastroenterology 2005;129:735–740.CrossRefGoogle ScholarPubMed
Trauner, M, Baghdasaryan, A, Claudel, T, et al. Targeting nuclear bile acid receptors for liver disease. Digest Dis 2011;29:98–102.CrossRefGoogle ScholarPubMed
Karpen, SJ. Exercising the nuclear option to treat cholestasis: CAR and PXR ligands. Hepatology 2005;42:266–269.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×